Tag: Tryp Therapeutics - Page 2 - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders

Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders

Post published:September 22, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida

Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida

Post published:August 24, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Dennis Langer, M.D., J.D. as Senior Advisor

Tryp Therapeutics Appoints Dennis Langer, M.D., J.D. as Senior Advisor

Post published:August 18, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations

Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations

Post published:August 10, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor

Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor

Post published:July 26, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Post published:July 21, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations

Post published:July 7, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with Alcami for Proprietary Formulations

Tryp Therapeutics Partners with Alcami for Proprietary Formulations

Post published:May 25, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

Post published:May 10, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with Fluence for Psychotherapy Design

Tryp Therapeutics Partners with Fluence for Psychotherapy Design

Post published:May 3, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.